Company intelligence / Profile preview

MetaRock

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

MetaRock is a technology company specializing in decentralized metaverse and blockchain-enabled industrial ecosystems, which was acquired by JP 3E Holdings in July 2025. The company provides a patented trade platform designed to facilitate secure, risk-free transcontinental transactions across various sectors, including commodities and healthcare. Within the JP 3E ecosystem, MetaRock's technology supports the K-Bio sector, which focuses on biomedical device manufacturing, pharmaceutical ingredients, and precision diagnostics. By integrating AI-driven decision-making and blockchain asset tokenization, MetaRock aims to optimize global supply chains and healthcare infrastructure.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

JP 3E Holdings

Beyond the preview

Go deeper on MetaRock.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MetaRock.

Explore the full profile